Analysts forecast that STRATA Skin Sciences Inc (NASDAQ:SSKN) will post earnings per share (EPS) of ($0.01) for the current quarter, Zacks reports. Two analysts have made estimates for STRATA Skin Sciences’ earnings. STRATA Skin Sciences posted earnings per share of ($0.10) during the same quarter last year, which would indicate a positive year over year growth rate of 90%. The company is scheduled to announce its next quarterly earnings report on Monday, April 1st.

On average, analysts expect that STRATA Skin Sciences will report full-year earnings of ($0.11) per share for the current financial year, with EPS estimates ranging from ($0.14) to ($0.07). For the next financial year, analysts forecast that the business will report earnings of $0.01 per share, with EPS estimates ranging from $0.00 to $0.01. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow STRATA Skin Sciences.

STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings results on Tuesday, November 13th. The medical device company reported ($0.01) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.04) by $0.03. The firm had revenue of $7.89 million during the quarter, compared to the consensus estimate of $7.64 million. STRATA Skin Sciences had a negative return on equity of 18.83% and a negative net margin of 18.33%.

SSKN has been the subject of a number of analyst reports. Dawson James initiated coverage on STRATA Skin Sciences in a research note on Tuesday, September 4th. They issued a “buy” rating for the company. Zacks Investment Research upgraded STRATA Skin Sciences from a “hold” rating to a “buy” rating and set a $2.75 price target for the company in a research note on Friday, November 16th. Finally, HC Wainwright set a $5.00 price target on STRATA Skin Sciences and gave the company a “buy” rating in a research note on Wednesday, November 14th.

Several hedge funds and other institutional investors have recently modified their holdings of SSKN. Alambic Investment Management L.P. bought a new position in shares of STRATA Skin Sciences during the 3rd quarter worth approximately $124,000. Dimensional Fund Advisors LP boosted its stake in shares of STRATA Skin Sciences by 70.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 66,813 shares of the medical device company’s stock worth $237,000 after acquiring an additional 27,586 shares during the period. Macquarie Group Ltd. boosted its stake in shares of STRATA Skin Sciences by 89.7% during the 2nd quarter. Macquarie Group Ltd. now owns 134,033 shares of the medical device company’s stock worth $275,000 after acquiring an additional 63,393 shares during the period. Renaissance Technologies LLC boosted its stake in shares of STRATA Skin Sciences by 164.6% during the 2nd quarter. Renaissance Technologies LLC now owns 293,499 shares of the medical device company’s stock worth $602,000 after acquiring an additional 182,579 shares during the period. Finally, EAM Investors LLC bought a new position in shares of STRATA Skin Sciences during the 3rd quarter worth approximately $830,000. Institutional investors own 26.94% of the company’s stock.

SSKN stock traded down $0.03 during mid-day trading on Wednesday, reaching $3.07. The company had a trading volume of 57,472 shares, compared to its average volume of 38,182. The company has a quick ratio of 4.03, a current ratio of 4.54 and a debt-to-equity ratio of 0.22. The company has a market cap of $93.12 million, a price-to-earnings ratio of 1.56 and a beta of 0.87. STRATA Skin Sciences has a 52 week low of $1.09 and a 52 week high of $3.88.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Featured Article: Understanding Market Liquidity

Get a free copy of the Zacks research report on STRATA Skin Sciences (SSKN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.